Aratana Therapeutics Inc., a Kansas City, Kan., biotechnology company, on Wednesday announced plans to raise $41.63 million in a public stock offering.
It would be the company’s third stock sale over the past 15 months.
Aratana, which is developing treatments for pets, said it plans to sell 4.5 million shares of common stock for $9.25 a share.
Earlier this year, the company bought exclusive licensing rights to four cancer treatments, including one that deals with bone tumors in dogs.
| The Star